KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Cash & Current Investments (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Cash & Current Investments for 11 consecutive years, with $336.1 million as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments rose 30.21% to $336.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $336.1 million through Dec 2025, up 30.21% year-over-year, with the annual reading at $336.1 million for FY2025, 30.21% up from the prior year.
  • Cash & Current Investments hit $336.1 million in Q4 2025 for Fulgent Genetics, down from $375.8 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $585.1 million in Q1 2022 to a low of $213.1 million in Q3 2024.
  • Historically, Cash & Current Investments has averaged $402.2 million across 5 years, with a median of $416.9 million in 2021.
  • Biggest five-year swings in Cash & Current Investments: soared 1730.97% in 2021 and later plummeted 54.45% in 2024.
  • Year by year, Cash & Current Investments stood at $450.5 million in 2021, then increased by 16.81% to $526.2 million in 2022, then dropped by 19.4% to $424.2 million in 2023, then crashed by 39.15% to $258.1 million in 2024, then skyrocketed by 30.21% to $336.1 million in 2025.
  • Business Quant data shows Cash & Current Investments for FLGT at $336.1 million in Q4 2025, $375.8 million in Q3 2025, and $292.9 million in Q2 2025.